First Patient Dosed in Phase 1 Clinical Trial of KB407 for the Treatment of Cystic Fibrosis

PITTSBURGH, July 03, 2023. Krystal Biotech, Inc. (the“Company”), a biotechnology company focused on developing and commercializing genetic medicines for patients with debilitating diseases, announced today that the first patient has...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials